Skip to the page

Data / Drug companies / Mullan Pharmaceutical Inc.

Mullan Pharmaceutical Inc.: 32 products in the FDA NDC directory, labeler code 83301

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Mullan Pharmaceutical Inc. (labeler code 83301) lists 32 products in the FDA National Drug Code Directory, covering 14 finished drugs by generic name. By type: 32 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 2, 2026.

The request: Watch Mullan Pharmaceutical Inc. (FDA labeler code 83301): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
83301
Products in commercial distribution
32
Packages
56
Finished drugs by generic name
14
Prescription products
32
Over the counter products
0
Flagged as original packager
30 of 30 products that carry the flag
Started marketing in the last 12 months
15
Earliest marketing start
May 1, 2023
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)32100%

Products by type

TypeProductsShare
Prescription drugs32100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Injection1237.5%
Capsule618.8%
Tablet, coated515.6%
Injection, solution412.5%
Liquid39.4%
Tablet, extended release26.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sugammadex83301-0078InjectionGeneric drugs (ANDA)November 2, 2026
Sugammadex83301-0077InjectionGeneric drugs (ANDA)November 2, 2026
Isoflurane, (Volatile for Inhalation)83301-0072LiquidGeneric drugs (ANDA)April 1, 2026
Isoflurane, (Volatile for Inhalation)83301-0071LiquidGeneric drugs (ANDA)April 1, 2026
Argatroban83301-0062InjectionGeneric drugs (ANDA)March 10, 2026
Sevoflurane, (Volatile for Inhalation)83301-0070LiquidGeneric drugs (ANDA)February 16, 2026
Ganirelix Acetate83301-0082Injection, solutionGeneric drugs (ANDA)January 13, 2026
Amikacin Sulfate83301-0023InjectionGeneric drugs (ANDA)January 12, 2026
Amikacin Sulfate83301-0022InjectionGeneric drugs (ANDA)January 12, 2026
Bumetanide83301-0081InjectionGeneric drugs (ANDA)January 9, 2026
Argatroban83301-0500InjectionGeneric drugs (ANDA)January 1, 2026
Labetalol Hydrochloride83301-0059InjectionGeneric drugs (ANDA)December 5, 2025
Labetalol Hydrochloride83301-0058InjectionGeneric drugs (ANDA)December 5, 2025
Vecuronium Bromide83301-0057InjectionGeneric drugs (ANDA)December 5, 2025
Vecuronium Bromide83301-0056InjectionGeneric drugs (ANDA)December 5, 2025
Bumetanide83301-0080InjectionGeneric drugs (ANDA)August 12, 2025
Bupropion Hydrochloride (XL)83301-0025Tablet, extended releaseGeneric drugs (ANDA)June 17, 2024
Bupropion Hydrochloride (XL)83301-0024Tablet, extended releaseGeneric drugs (ANDA)June 17, 2024
Celecoxib83301-0028CapsuleGeneric drugs (ANDA)January 1, 2024
Celecoxib83301-0012CapsuleGeneric drugs (ANDA)January 1, 2024
Celecoxib83301-0011CapsuleGeneric drugs (ANDA)January 1, 2024
Metformin Hydrochloride83301-0010Tablet, coatedGeneric drugs (ANDA)January 1, 2024
Metformin Hydrochloride83301-0009Tablet, coatedGeneric drugs (ANDA)January 1, 2024
Metformin Hydrochloride83301-0008Tablet, coatedGeneric drugs (ANDA)January 1, 2024
Gabapentin83301-0002Tablet, coatedGeneric drugs (ANDA)January 1, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.